Director, Late-Stage Formulation Development
Kymera TherapeuticsWatertown, Massachusetts, United States
Posted May 6, 2026
195000 - 275000 USD
Full Time
About the Company
Kymera Therapeutics is a clinical-stage biotechnology company pioneering the field of targeted protein degradation to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives.
Job Description
Kymera is seeking a Director of Formulation Development to assist in the development of late-stage oral drug product development and commercial manufacturing strategies to support Kymera’s small molecule pipeline from Phase 2/3 through commercialization.
Requirements
- D. in Pharmaceutics, Pharmaceutical Sciences, Chemical Engineering, or related field with 10+ years of industry experience, or M.S. with 15+ years of relevant experience.
- Demonstrated expertise in late-stage small molecule formulation development and manufacturing for oral solid dosage forms.
- Proven track record of advancing compounds through Phase 3, regulatory approval, process validation and commercialization.
- Strong experience with CDMO oversight, technology transfer, and commercial supply management.
- Working knowledge of global regulatory CMC requirements, including NDA preparation and inspection readiness.
- Excellent leadership, communication, and cross-functional influencing skills.
Benefits
- Competitive compensation package
- Performance-driven pay
- Eligibility for annual bonus
- Equity participation
- Comprehensive benefits
